Dexmedetomidine - BioXcel Therapeutics
At a glance
- Drug Originator Inveni
- Drug Licenced by BioXcel Therapeutics
- Drug Class Antidepressants; Antipsychotics; Anxiolytics; Behavioural disorder therapies; Drug withdrawal therapies; Hypnosedatives; Imidazoles; Non-opioid analgesics; Sleep disorder therapies; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists
- USA Patent Applicants BIOXCEL
- USA Patents 17
- NDAs 1
- International Patents 75
- Patent Applications 242
Disclaimer